Clinical trials: Newly Diagnosed Peripheral T-cell Lymphoma
- Condition Newly Diagnosed Peripheral T-cell Lymphoma
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Lymphoma, T-Cell, Peripheral
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to make Peripheral T-cell lymphoma disappear (for any period of time) and potentially lengthen life.
- Trial name
- NCT00211185
- Testing
- Denileukin diftitox, Cyclophosphamide, Doxorubicin
- Where
- 49 sites in United States
- Volunteers
- 49 people
- Sponsor
- Eisai Inc.